The Top 500 IVD Companies Worldwide

Publisher Name :
Date: 23-Nov-2016
No. of pages: 846

Did you know?


  • Transasia Bio-Medicals is India’s largest in-vitro diagnostics company.

  • Diachel SA is the leading independent in-vitro diagnostics distributor in Greece, offering complete laboratory solutions, from sales to after-sales support and service.

  • Una Health Ltd., the fastest growing diagnostics distributor in the United Kingdom, specialises in bringing innovative point-of-care devices to the market.

  • Abbott Diagnostics is #1 in immunoassay and blood screening worldwide.

  • OraSure Technologies, Inc. has 327 employees.

  • Marcel van Kasteel is Vice President & General Manager at Philips Handheld Diagnostics.

  • OvaGene is unlike any other molecular diagnostics company; their only focus in on women's pelvic cancers and related conditions.

  • In June, 2016, GenMark achieved the CE Mark for its ePlex sample-to-answer multiplex molecular diagnostics System and ePlex Respiratory Pathogen (RP) Panel.

  • Trinity Biotech plc’s total revenues for fiscal year 2015 were $100.2m.

  • Genetic Signatures is seeking to enter the U.S. market with strategic customer relationships and partnerships.

  • Micronics, Inc., a leading developer of near-patient point-of-care in vitro diagnostics products, is a wholly owned subsidiary of Sony Corporation of America.


These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 500 IVD Companies Worldwide’.

This unique and exciting report identifies and profiles the leading 500 manufacturers and distributors of core laboratory, point-of-care and molecular diagnostics. They are located right across the globe from the United States and Europe to India and China.

Profile information for companies in ‘The Top 500 IVD Companies Worldwide’ includes:


  • Company Contact Information Address, Telephone and Fax Numbers, Email and Website Addresses

  • Key Company Decision Makers From CEO and Main Board, to Key Senior Managers

  • Specialised fields such as Company Description, Products, Manufacturers Represented, Clinical Specialties/Diseases, Countries Served, Year Established, Number of Employees, Revenue ($U.S. million), Parent Company, Location Status, Ownership, Stock Exchange/Ticker Symbol


Report Target Market:


  • IVD Manufacturers

  • IVD Suppliers

  • IVD Distributors

  • IVD Industry Associations


Note: Most people will be aware of some of the major IVD companies such as Abacus ALS, Axon Lab, EKF Diagnostics, Nova Biomedical and QIAGEN but this major new report looks at all 500 of the top IVD companies worldwide companies like:

Sekisui Diagnostics Sekisui Diagnostics is a diverse company with broad product lines, a global sales and distribution network, extensive product development capabilities, state of the art manufacturing facilities and deep diagnostics expertise. Over 1.5 billion tests are performed each year using the Company’s clinical chemistry products. Sekisui Diagnostics is headquartered in Lexington, MA, United States, has annual revenue of $175.0 million and over 525 employees worldwide. The Company is led by Bob Schruender, President and Chief Operating Officer. Sekisui Diagnostics is a member of AdvaMedDX.

Inter Medico Founded in 1979 by Dan Lichtman, President, Inter Medico is the largest Canadian-owned distributor of in-vitro diagnostics. The Company has strategic alliances with world-class manufacturers including Abbott Molecular, Biokit, Cepheid, Dako, Grifols, Helena Laboratories, Immunodiagnostic Systems, Inova Diagnostics, Siemens Healthcare and Trinity Biotech. Inter Medico’s products can be found in Canadian hospitals, reference laboratories, universities, and the biopharmaceutical industry.

Chembio Diagnostic Systems, Inc. Headquartered in Medford, New York, United States, Chembio Diagnostic Systems, Inc. (Nasdaq: CEMI) develops, manufactures, licenses and markets point-of-care diagnostic tests and technology for the detection of infectious diseases. The Company’s Dual Path Platform (DPP®) technology is providing it with a significant pipeline of business opportunities for the development and manufacture of new products. On November 3, 2015 Chembio announced plans to commercialise multiple combination DPP® Malaria Assays to identify plasmodium falciparum and other plasmodium infections. Founded in 1985, Chembio had revenues of $U.S. 27.6 million in 2014. It currently has 166 employees and is led by John J. Sperzel, Chief Executive Officer.

Triolab AS Founded in 1991, Danish company Triolab AS offers an extensive product range from point-of-care testing to full automation of clinical laboratories in the fields of coagulation, haematology, clinical chemistry, transfusion and transplantation diagnostics, molecular diagnostics and microbiology. The Company represents many leading diagnostics products manufacturers and has customers in all healthcare segments, from small clinical laboratories to large laboratory centres and hospital departments Triolab is part of the Swedish Addtech Group and has sister companies in Finland, Norway and Sweden. Together they are one of the leading diagnostic suppliers in the Nordic area. Triolab is led by Finn Ulbæk Andersen, Managing Director.

Biocartis Group NV Headquartered in Mechelen, Belgium, Biocartis Group NV is an innovative commercial stage, molecular diagnostics company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. The Company’s proprietary MDxIdylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring. Biocartis Group NV is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases, the fastest and largest growing segments of the $U.S. 5.0 billion MDx market. The Company employs 300 people and had revenue of $U.S. 16.7 million in 2015. Biocartis Group NV has been listed on Euronext Brussels (BCART) since April 2015 and is led by Rudi Pauwels, Chief Executive Officer.

Research Facts is one of the world’s leading companies in life sciences publishing. It has a large portfolio of best-selling reports spanning diagnostics, pharmaceuticals, biotechnology and medical devices. It’s customers include most of the world’s major companies in these sectors e.g. Abbott Laboratories, ACON Laboratories, Alcon, Allergan, Aurobindo Pharma, Axis-Shield, Baxter, Bayer, B. Braun, BD, Biomerieux, Biomet, BoehringerIngelheim, CareFusion, Covance, Covidien, C.R. Bard, Edwards Lifesciences, Fresenius, GE Healthcare, Genzyme, HemoCue, Intuitive Surgical, Ipsen, Johnson & Johnson, Medtronic, Merit Medical Systems, Millipore, Mölnlycke Health Care, Novartis, Paul Hartmann, Philips Medical, Qiagen, Siemens Healthcare, Smith & Nephew, Synthes, Teleflex, Teva, Zentiva etc.. Research Facts also counts many multinational financial services, law and management consulting firms such as Bain & Company, McKinsey & Company and The Boston Consulting Group among its customers.

Research Facts currently has customers in some forty countries across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Mauritius, Netherlands, Pakistan, Peru, Portugal, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.

Research Facts' reports help you make informed decisions about the markets and organisations that affect your business.


  • Learn more about your target markets and target companies

  • Top level research on all the major players in a market

  • See which organisations dominate your major markets

  • Get detailed information on particular organisations

The Top 500 IVD Companies Worldwide

Table of Contents

N/A

  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • In-Vitro Diagnostics Market Global Briefing 2017 Including: Point-of-Care Diagnostics, Immunochemistry, Molecular Diagnostics, Microbiology, Hematology and Immunohematology Covering: Siemens Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation
    Published: 06-Feb-2017        Price: US 1000 Onwards        Pages: 26
    In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person's state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. The In-Vitro Diagnostics Market Global Briefing provides strategists, marketers and senior management with the critical information they need to assess the global in-vitro diagnostics market. Reasons t......
  • The Top 600 In-Vitro Diagnostics Companies Worldwide:
    Published: 26-Jan-2017        Price: US 5005 Onwards        Pages: 1051
    Did you know? Transasia Bio-Medicals is India’s largest in-vitro diagnostics company. Diachel SA is the leading independent in-vitro diagnostics distributor in Greece, offering complete laboratory solutions, from sales to after-sales support and service. Una Health Ltd., the fastest growing diagnostics distributor in the United Kingdom, specialises in bringing innovative point-of-care devices to the market. Abbott Diagnostics......
  • 2017-2021 Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 9850 Onwards        Pages: 366
    About this ReportThis new 366-page report from VPGMarketResearch.com presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales forecasts by country and market segment, including:......
  • 2017-2021 France Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 1950 Onwards        Pages: 282
    About This ReportThis new 282-page report from VPGMarketResearch.com presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report:......
  • 2017-2021 Germany Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 1950 Onwards        Pages: 283
    About This ReportThis new 283-page report from VPGMarketResearch.com presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report:......
  • 2017-2021 Italy Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 1950 Onwards        Pages: 281
    About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.     In addition to market share and sales forecasts......
  • 2017-2021 Japan Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 2400 Onwards        Pages: 282
    About This ReportThis new 282-page report from VPGMarketResearch.com presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.    In addition to market share and sales forecasts......
  • 2017-2021 Spain Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 1950 Onwards        Pages: 281
    About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.     In addition to market share and sales forecasts......
  • 2017-2021 UK Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
    Published: 24-Jan-2017        Price: US 1950 Onwards        Pages: 281
    About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.In addition to market share and sales forecasts, the report:-&n......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs